Reckitt rallies after Mead Johnson wins baby formula case

Reckitt Benckiser shot to the top of the FTSE 100 on Tuesday after an Illinois court ruled in favour of its Mead Johnson unit in a trial alleging that its baby formula was linked to a deadly bowel disease in premature babies.

Reckitt Benckiser Group
01 September 2026 10:38:01

Source: Sharecast

In a statement on Monday, Mead Johnson said it welcomed the unanimous jury verdict in the company's favour in the Inman case in the US District Court for the Northern District of Illinois.

It was the first bellwether case against the business tried in the federal Multi-District Litigation (MDL) involving allegations concerning the cause of necrotizing enterocolitis (NEC), a serious gastrointestinal condition that primarily affects premature infants.

There are currently no outstanding jury verdicts in the overall NEC litigation against Mead Johnson.

"Today’s verdict affirms Mead Johnson’s view that the science doesn’t support the claims here or in the litigation more broadly," it said. "We strongly reject any assertion that any of our products cause NEC, and we will continue to vigorously defend ourselves against all such claims in the interest of safeguarding the health of premature babies."

At 1035 BST, Reckitt shares were up 4.5% at 5,362p.

Russ Mould, investment director at AJ Bell, said: "This bellwether ruling removes a significant area of doubt surrounding the business which could help clear the way to a sale which Reckitt has been pursuing for some time.

"Any deal would bring to an end a damaging episode for Reckitt which bought Mead Johnson in 2017 and has been counting the costs for most of the intervening period."

Transferring your account

Transfer your existing ISAs and Share Dealing Accounts and you could save money. In order to transfer, log in to your existing account and complete the online application form. We’ll do the rest for you. It’s free to transfer (we will not charge you). Please check your current provider to see if they have any charges for transferring.

Transfer to us

FTSE 100 ( UKX )

Isin: N/A

Exchange: London Stock Exchange

Sell:

0.00

Buy:

0.00

Change: 2.65 ( 0.02 %)

Date:

10/09/2026 - 08:47

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Bank of Scotland is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Bank of Scotland Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales No. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

The information contained on this website and in the tools, data, prices, news, charts, fundamentals and other content made available through it is provided by Communify Europe Limited, unless expressly stated otherwise.

The information is provided for informational purposes only. It does not constitute investment advice, a personal recommendation, investment research, a research recommendation, an invitation or inducement to engage in investment activity, or a recommendation to buy, sell or hold any share, company, fund, investment vehicle or other financial instrument. Communify Europe Limited does not assess the suitability or appropriateness of any investment for any user.

The information is based on sources that Communify Europe Limited considers reliable. However, Communify Europe Limited does not guarantee that the information is accurate, complete, current, uninterrupted, secure or error-free. Prices, quotes and trades may be delayed by at least fifteen minutes unless expressly stated to be provided in real time.

Past performance is not an indicator of future performance. Communify Europe Limited does not guarantee the return of any investment or the performance of any security, company, investment vehicle, index, underlying asset or market. The value of investments may rise or fall, and investors may lose all or part of the amount invested.

To the extent permitted by applicable law, Communify Europe Limited will not be liable for any loss or damage arising from use of the information contained on this website. Nothing in this notice excludes or limits liability for fraud, death or personal injury caused by negligence, breach of the duty to provide services with reasonable care and skill, or any other liability that cannot be excluded or limited under applicable law. Terms and conditions apply.

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.